| - GRCh37:
- Chr1:44361728-45333408
- GRCh38:
- Chr1:43896056-44867736
| LOC112590795, LOC122056854, LOC122056855, LOC122056856, LOC126805725, LOC126805726, LOC126805727, LOC128900003, LOC128900004, LOC129388505, LOC129930392, LOC129930393, LOC129930394, LOC129930395, LOC129930396, LOC129930397, LOC129930398, LOC129930399, LOC129930400, LOC129930401, LOC129930402, LOC129930403, LOC129930404, LOC129930405, LOC129930406, LOC129930407, LOC129930408, LOC129930409, LOC129930410, LOC129930411, LOC129930412, LOC129930413, LOC129930414, LOC129930415, LOC129930416, LOC129930417, LOC129930418, LOC129930419, LOC129930420, LOC129930421, LOC129930422, LOC129930423, LOC129930424, LOC129930425, LOC129930426, LOC129930427, LOC129930428, LOC132088721, LOC132088722, MIR5584, PLK3, PTCH2, RNF220, RNU5D-1, RNU5F-1, RPS8, SLC6A9, SNORA110, SNORD145, SNORD160, SNORD38A, SNORD38B, SNORD46, SNORD55, ST3GAL3, TMEM53, ARMH1, ARTN, ATP6V0B, B4GALT2, BEST4, BTBD19, CCDC24, DMAP1, DPH2, DYNLT4, EIF2B3, ERI3, ERI3-IT1, IPO13, KIF2C, KLF17, KLF18, LOC101929609, LOC110120642, LOC110120644, LOC110121214, LOC112590792, LOC112590793, LOC112590794 | | See cases | Uncertain significance (Dec 22, 2010) | no assertion criteria provided |
| - GRCh37:
- Chr1:45179509-45748571
- GRCh38:
- Chr1:44713837-45282899
| ARMH1, BEST4, BTBD19, DYNLT4, EIF2B3, HECTD3, KIF2C, LOC112590799, LOC122056855, LOC122056856, LOC126805727, LOC129388506, LOC129388507, LOC129930418, LOC129930419, LOC129930420, LOC129930421, LOC129930422, LOC129930423, LOC129930424, LOC129930425, LOC129930426, LOC129930427, LOC129930428, LOC129930429, LOC129930430, LOC129930431, LOC129930432, LOC129930433, PLK3, PTCH2, RNU5D-1, RNU5F-1, RPS8, SNORD160, SNORD38A, SNORD38B, SNORD46, SNORD55, UROD, ZSWIM5 | | See cases | Uncertain significance (Aug 12, 2011) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45282802-45696079
- GRCh38:
- Chr1:44817130-45230407
| EIF2B3, HECTD3, LOC112590799, LOC129388506, LOC129388507, LOC129930428, LOC129930429, LOC129930430, LOC129930431, LOC129930432, LOC129930433, PTCH2, UROD, ZSWIM5 | | See cases | Uncertain significance (Sep 21, 2012) | no assertion criteria provided |
| - GRCh37:
- Chr1:45287546
- GRCh38:
- Chr1:44821874
| PTCH2 | | not provided | Likely benign (Apr 1, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288092
- GRCh38:
- Chr1:44822420
| PTCH2 | G1203R | Gorlin syndrome | Uncertain significance (Aug 25, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288093
- GRCh38:
- Chr1:44822421
| PTCH2 | | Gorlin syndrome | Likely benign (Oct 2, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288098
- GRCh38:
- Chr1:44822426
| PTCH2 | A1201P | PTCH2-related condition, Gorlin syndrome | Uncertain significance (Sep 8, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288109
- GRCh38:
- Chr1:44822437
| PTCH2 | G1197fs | Gorlin syndrome | Uncertain significance (May 7, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288109
- GRCh38:
- Chr1:44822437
| PTCH2 | G1197E | Gorlin syndrome | Uncertain significance (Jan 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288110
- GRCh38:
- Chr1:44822438
| PTCH2 | G1197R | Gorlin syndrome | Benign (Nov 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288115
- GRCh38:
- Chr1:44822443
| PTCH2 | S1195F | Breast carcinoma | Uncertain significance (Sep 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288116
- GRCh38:
- Chr1:44822444
| PTCH2 | S1195T | Inborn genetic diseases | Uncertain significance (May 11, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288133
- GRCh38:
- Chr1:44822461
| PTCH2 | S1189T | See cases, Gorlin syndrome | Uncertain significance (Aug 23, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288135
- GRCh38:
- Chr1:44822463
| PTCH2 | | Gorlin syndrome | Likely benign (Feb 24, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288146
- GRCh38:
- Chr1:44822474
| PTCH2 | P1185S | Gorlin syndrome | Uncertain significance (Nov 11, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288151
- GRCh38:
- Chr1:44822479
| PTCH2 | W1183* | Gorlin syndrome | Uncertain significance (Aug 31, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288156-45288157
- GRCh38:
- Chr1:44822484-44822485
| PTCH2 | P1182fs | Gorlin syndrome | Uncertain significance (Aug 12, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288175
- GRCh38:
- Chr1:44822503
| PTCH2 | H1175R | Gorlin syndrome | Uncertain significance (May 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288181
- GRCh38:
- Chr1:44822509
| PTCH2 | Y1173C | Gorlin syndrome | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288193
- GRCh38:
- Chr1:44822521
| PTCH2 | L1169fs | Gorlin syndrome | Uncertain significance (Jun 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288193
- GRCh38:
- Chr1:44822521
| PTCH2 | L1169P | Gorlin syndrome | Uncertain significance (Nov 6, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288194
- GRCh38:
- Chr1:44822522
| PTCH2 | L1169fs | Gorlin syndrome | Uncertain significance (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288195
- GRCh38:
- Chr1:44822523
| PTCH2 | | Gorlin syndrome | Likely benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288195
- GRCh38:
- Chr1:44822523
| PTCH2 | | Gorlin syndrome | Likely benign (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288199
- GRCh38:
- Chr1:44822527
| PTCH2 | P1167L | Gorlin syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288216
- GRCh38:
- Chr1:44822544
| PTCH2 | | Gorlin syndrome | Likely benign (Aug 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288220
- GRCh38:
- Chr1:44822548
| PTCH2 | M1160T | Gorlin syndrome | Uncertain significance (Aug 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288222
- GRCh38:
- Chr1:44822550
| PTCH2 | | Gorlin syndrome | Likely benign (May 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288226
- GRCh38:
- Chr1:44822554
| PTCH2 | T1158S | Gorlin syndrome | Uncertain significance (Aug 30, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288228
- GRCh38:
- Chr1:44822556
| PTCH2 | | not provided | Likely benign (Mar 30, 2018) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288231
- GRCh38:
- Chr1:44822559
| PTCH2 | | Gorlin syndrome | Likely benign (Sep 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288243
- GRCh38:
- Chr1:44822571
| PTCH2 | | Gorlin syndrome | Likely benign (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288245
- GRCh38:
- Chr1:44822573
| PTCH2 | S1152G | Gorlin syndrome | Uncertain significance (May 31, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288246
- GRCh38:
- Chr1:44822574
| PTCH2 | | Gorlin syndrome | Likely benign (May 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288268
- GRCh38:
- Chr1:44822596
| PTCH2 | G1144E | Gorlin syndrome | Uncertain significance (Dec 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288269
- GRCh38:
- Chr1:44822597
| PTCH2 | G1144R | Gorlin syndrome | Uncertain significance (Jul 11, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288272
- GRCh38:
- Chr1:44822600
| PTCH2 | W1143G | Gorlin syndrome | Uncertain significance (Jul 14, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288282
- GRCh38:
- Chr1:44822610
| PTCH2 | | Gorlin syndrome | Likely benign (Mar 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288288
- GRCh38:
- Chr1:44822616
| PTCH2 | | Gorlin syndrome | Likely benign (Aug 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288289
- GRCh38:
- Chr1:44822617
| PTCH2 | Q1137R | Gorlin syndrome | Uncertain significance (Aug 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288289
- GRCh38:
- Chr1:44822617
| PTCH2 | Q1137P | Gorlin syndrome | Uncertain significance (Aug 28, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288307
- GRCh38:
- Chr1:44822635
| PTCH2 | L1131P | Gorlin syndrome | Uncertain significance (Aug 20, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288317
- GRCh38:
- Chr1:44822645
| PTCH2 | P1128S | Gorlin syndrome | Uncertain significance (May 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288336
- GRCh38:
- Chr1:44822664
| PTCH2 | I1121M | Gorlin syndrome, Basal cell carcinoma, susceptibility to, 1, Gorlin syndrome, Medulloblastoma, not provided | Benign/Likely benign (Oct 13, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288341
- GRCh38:
- Chr1:44822669
| PTCH2 | V1120M | not specified | Uncertain significance (Aug 15, 2023) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288345
- GRCh38:
- Chr1:44822673
| PTCH2 | | Gorlin syndrome | Likely benign (Mar 16, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288349-45288350
- GRCh38:
- Chr1:44822677-44822678
| PTCH2 | | Gorlin syndrome | Likely benign (Jul 19, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288355
- GRCh38:
- Chr1:44822683
| PTCH2 | | Gorlin syndrome | Likely benign (Nov 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288481
- GRCh38:
- Chr1:44822809
| PTCH2 | | not provided | Likely benign (Apr 16, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288492
- GRCh38:
- Chr1:44822820
| PTCH2 | | not provided | Likely benign (Feb 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288527
- GRCh38:
- Chr1:44822855
| PTCH2 | | not provided | Benign (Feb 7, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288725
- GRCh38:
- Chr1:44823053
| PTCH2 | | Gorlin syndrome | Likely benign (Apr 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288726
- GRCh38:
- Chr1:44823054
| PTCH2 | | Gorlin syndrome | Likely benign (Oct 7, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288727
- GRCh38:
- Chr1:44823055
| PTCH2 | | Gorlin syndrome | Likely benign (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288733
- GRCh38:
- Chr1:44823061
| PTCH2 | | Gorlin syndrome | Likely benign (Jul 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288736
- GRCh38:
- Chr1:44823064
| PTCH2 | | Basal cell carcinoma, somatic | Pathogenic (Feb 1, 1999) | no assertion criteria provided |
| - GRCh37:
- Chr1:45288746
- GRCh38:
- Chr1:44823074
| PTCH2 | P1118S | Gorlin syndrome | Uncertain significance (Sep 17, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288750
- GRCh38:
- Chr1:44823078
| PTCH2 | | Basal cell carcinoma, susceptibility to, 1, Gorlin syndrome | Likely benign (Jul 7, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288751
- GRCh38:
- Chr1:44823079
| PTCH2 | P1116L | Basal cell carcinoma, susceptibility to, 1, Gorlin syndrome, Medulloblastoma, Gorlin syndrome | Uncertain significance (Sep 17, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288753
- GRCh38:
- Chr1:44823081
| PTCH2 | | Gorlin syndrome | Likely benign (Sep 15, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288758
- GRCh38:
- Chr1:44823086
| PTCH2 | | Gorlin syndrome | Benign (Oct 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288759
- GRCh38:
- Chr1:44823087
| PTCH2 | | Gorlin syndrome | Likely benign (Apr 22, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288769
- GRCh38:
- Chr1:44823097
| PTCH2 | L1110P | Gorlin syndrome | Uncertain significance (May 29, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288775-45288776
- GRCh38:
- Chr1:44823103-44823104
| PTCH2 | | Gorlin syndrome | Uncertain significance (Aug 24, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288785
- GRCh38:
- Chr1:44823113
| PTCH2 | V1105M | Inborn genetic diseases, Gorlin syndrome | Uncertain significance (Sep 26, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288786
- GRCh38:
- Chr1:44823114
| PTCH2 | | Gorlin syndrome | Likely benign (Feb 14, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288787
- GRCh38:
- Chr1:44823115
| PTCH2 | L1104P | Inborn genetic diseases | Uncertain significance (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288807
- GRCh38:
- Chr1:44823135
| PTCH2 | | Gorlin syndrome | Likely benign (Feb 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288811
- GRCh38:
- Chr1:44823139
| PTCH2 | T1096M | Gorlin syndrome | Uncertain significance (Jun 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288811-45288812
- GRCh38:
- Chr1:44823139-44823140
| PTCH2 | T1096fs | Gorlin syndrome | Uncertain significance (May 28, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288814
- GRCh38:
- Chr1:44823142
| PTCH2 | L1095P | Gorlin syndrome | Uncertain significance (Aug 26, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288818
- GRCh38:
- Chr1:44823146
| PTCH2 | V1094L | Gorlin syndrome | Uncertain significance (Oct 21, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288826
- GRCh38:
- Chr1:44823154
| PTCH2 | A1091E | Gorlin syndrome | Uncertain significance (Jun 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288826
- GRCh38:
- Chr1:44823154
| PTCH2 | A1091V | Gorlin syndrome | Uncertain significance (Sep 21, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288827
- GRCh38:
- Chr1:44823155
| PTCH2 | A1091T | Gorlin syndrome | Uncertain significance (Sep 17, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288828
- GRCh38:
- Chr1:44823156
| PTCH2 | | Gorlin syndrome | Uncertain significance (Aug 13, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288828
- GRCh38:
- Chr1:44823156
| PTCH2 | | Gorlin syndrome | Likely benign (Oct 9, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288829
- GRCh38:
- Chr1:44823157
| PTCH2 | A1090V | Gorlin syndrome | Uncertain significance (Jun 28, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288835
- GRCh38:
- Chr1:44823163
| PTCH2 | F1088Y | Gorlin syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288840
- GRCh38:
- Chr1:44823168
| PTCH2 | R1086S | Gorlin syndrome | Uncertain significance (Mar 4, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288843-45288845
- GRCh38:
- Chr1:44823171-44823173
| PTCH2 | | Gorlin syndrome | Uncertain significance (Sep 29, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288856
- GRCh38:
- Chr1:44823184
| PTCH2 | | Gorlin syndrome | Benign (Apr 1, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288856
- GRCh38:
- Chr1:44823184
| PTCH2 | | Gorlin syndrome | Likely benign (Mar 10, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288857
- GRCh38:
- Chr1:44823185
| PTCH2 | | Gorlin syndrome | Likely benign (May 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288859
- GRCh38:
- Chr1:44823187
| PTCH2 | | Gorlin syndrome | Likely benign (Jul 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288900
- GRCh38:
- Chr1:44823228
| PTCH2 | | Gorlin syndrome | Likely benign (Oct 8, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288901
- GRCh38:
- Chr1:44823229
| PTCH2 | | Gorlin syndrome | Likely benign (Oct 23, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288902
- GRCh38:
- Chr1:44823230
| PTCH2 | | Gorlin syndrome | Likely benign (Jun 2, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288912
- GRCh38:
- Chr1:44823240
| PTCH2 | | Gorlin syndrome | Uncertain significance (Sep 12, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288914
- GRCh38:
- Chr1:44823242
| PTCH2 | | Gorlin syndrome | Uncertain significance (Jul 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288921
- GRCh38:
- Chr1:44823249
| PTCH2 | I1084T | Inborn genetic diseases | Uncertain significance (Jun 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288926
- GRCh38:
- Chr1:44823254
| PTCH2 | | Gorlin syndrome | Likely benign (Jul 15, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288939
- GRCh38:
- Chr1:44823267
| PTCH2 | G1078V | Gorlin syndrome | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288956
- GRCh38:
- Chr1:44823284
| PTCH2 | | Gorlin syndrome | Benign (Oct 30, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288962
- GRCh38:
- Chr1:44823290
| PTCH2 | L1070F | Gorlin syndrome, not specified, Inborn genetic diseases
| Uncertain significance (Aug 15, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288982
- GRCh38:
- Chr1:44823310
| PTCH2 | D1064N | Gorlin syndrome | Uncertain significance (Aug 20, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288983
- GRCh38:
- Chr1:44823311
| PTCH2 | | Gorlin syndrome, not provided | Likely benign (Oct 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr1:45288987
- GRCh38:
- Chr1:44823315
| PTCH2 | V1062G | Basal cell carcinoma, susceptibility to, 1 | Uncertain significance (Sep 11, 2019) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288988
- GRCh38:
- Chr1:44823316
| PTCH2 | V1062M | Gorlin syndrome | Likely benign (Oct 25, 2022) | criteria provided, single submitter |
| - GRCh37:
- Chr1:45288989
- GRCh38:
- Chr1:44823317
| PTCH2 | | Gorlin syndrome, not provided | Likely benign (Jul 1, 2023) | criteria provided, multiple submitters, no conflicts |